US FDA panel backs Sanofi-AstraZeneca's preventive RSV therapy
The U.S. Food and Drug Administration advisers on Thursday backed the use of Sanofi and partner AstraZenecas experimental antibody to prevent respiratory syncytial virus infections in infants... | June 8, 2023
Raghav Mahobe Maju Samuel Drug Administration Mariam Sunny Astrazeneca Plc Stock Exchange Press Release
Source: marketscreener.com